Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

VYNE Therapeutics (VYNE) Exchange Rate Effect (2019 - 2021)

VYNE Therapeutics (VYNE) has disclosed Exchange Rate Effect for 3 consecutive years, with -$1000.0 as the latest value for Q2 2021.

  • For the quarter ending Q2 2021, Exchange Rate Effect fell 102.63% year-over-year to -$1000.0, compared with a TTM value of -$1000.0 through Mar 2022, down 102.56%, and an annual FY2020 reading of $1000.0, down 97.56% over the prior year.
  • Exchange Rate Effect was -$1000.0 for Q2 2021 at VYNE Therapeutics, down from $1000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $38000.0 in Q2 2020 and bottomed at -$37000.0 in Q1 2020.
  • Average Exchange Rate Effect over 3 years is $5250.0, with a median of $7000.0 recorded in 2019.
  • The sharpest move saw Exchange Rate Effect tumbled 384.62% in 2020, then surged 102.7% in 2021.
  • Year by year, Exchange Rate Effect stood at $16000.0 in 2019, then soared by 137.5% to $38000.0 in 2020, then tumbled by 102.63% to -$1000.0 in 2021.
  • Business Quant data shows Exchange Rate Effect for VYNE at -$1000.0 in Q2 2021, $1000.0 in Q1 2021, and $38000.0 in Q2 2020.